Financial Architects (New Jersey)’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-500
| Closed | -$1K | – | 850 |
|
|
2020
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 837 |
|
|
2020
Q1 | $1K | Hold |
500
| – | – | ﹤0.01% | 836 |
|
|
2019
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 859 |
|
|
2019
Q3 | $1K | Hold |
500
| – | – | ﹤0.01% | 988 |
|
|
2019
Q2 | $2K | Sell |
500
-3,000
| -86% | -$9.73K | ﹤0.01% | 1115 |
|
|
2019
Q1 | $13K | Hold |
3,500
| – | – | ﹤0.01% | 1038 |
|
|
2018
Q4 | $10K | Hold |
3,500
| – | – | ﹤0.01% | 1007 |
|
|
2018
Q3 | $9K | Hold |
3,500
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q2 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1061 |
|
|
2018
Q1 | $10K | Hold |
3,500
| – | – | ﹤0.01% | 1096 |
|
|
2017
Q4 | $9K | Hold |
3,500
| – | – | ﹤0.01% | 1190 |
|
|
2017
Q3 | $12K | Hold |
3,500
| – | – | ﹤0.01% | 1095 |
|
|
2017
Q2 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1198 |
|
|
2017
Q1 | $8K | Hold |
3,500
| – | – | ﹤0.01% | 1202 |
|
|
2016
Q4 | $7K | Hold |
3,500
| – | – | ﹤0.01% | 1111 |
|
|
2016
Q3 | $12K | Hold |
3,500
| – | – | ﹤0.01% | 971 |
|
|
2016
Q2 | $11K | Buy |
3,500
+3,000
| +600% | +$10K | ﹤0.01% | 967 |
|
|
2016
Q1 | $2K | Buy |
+500
| New | +$1.56K | ﹤0.01% | 1116 |
|
|
2015
Q3 | – | Sell |
-500
| Closed | -$3K | – | 1199 |
|
|
2015
Q2 | $3K | Buy |
+500
| New | +$3.35K | ﹤0.01% | 1085 |
|
|
2015
Q1 | – | Sell |
-500
| Closed | -$4K | – | 1101 |
|
|
2014
Q4 | $4K | Hold |
500
| – | – | ﹤0.01% | 892 |
|
|
2014
Q3 | $4K | Hold |
500
| – | – | ﹤0.01% | 792 |
|
|
2014
Q2 | $5K | Buy |
+500
| New | +$4.46K | ﹤0.01% | 802 |
|
Other funds holding PDLI
PWAM
SPC
MAP
BIP